Navigation Links
Arsenal Capital Partners verwerft Certara, leider in geneesmiddelontwikkeling op basis van modellen
Date:12/20/2013

n van een breed spectrum aan softwareproducten en consultancyservices, die uiteenlopen van moleculaire ontdekking tot klinische ontwikkeling, met een speciale focus op de ondersteuning van translatorische benaderingen van de geneesmiddelontwikkeling. Certara is een toonaangevende leverancier van hulpmiddelen voor geneesmiddelontwikkeling op basis van modellen en is gevormd door de acquisitie en integratie van de industrieleiders Tripos®, Simcyp™ en Pharsight® Corporation. Elk merk in de Certara-familie richt zich op een belangrijke fase in het proces van de geneesmiddelontdekking en –ontwikkeling en gezamenlijk bieden ze een unieke set aan mogelijkheden tot wetenschappelijke modellering, analyse en simulatie die de interdisciplinaire benaderingen faciliteren die nodig zijn voor translatorische wetenschappelijke initiatieven. Voor meer informatie bezoekt u www.certara.com.

Voor meer informatie neemt u contact op met:Financiële vragen

Chris Tofalli

+1-914-834-4334;

chris@tofallipr.comVragen over Arsenal

David Seldin

+1-202-393-7337;

dseldin@brunswickgroup.comVragen over Certara

Lisa Osborne

+1-206-992-5245;

lisa@ranahealth.com 

 

 


'/>"/>
SOURCE Arsenal Capital Partners
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
6. Generex Secures Commitments for $3.6M Capital Raise
7. Life Technologies to Present at Barclays Capital Global Healthcare Conference
8. WestPark Capitals Michael Wechsler Comments on the Life Insurance Market
9. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
10. SeraCare Shareholders Approve Acquisition by Linden Capital Partners
11. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Aytu BioScience, Inc. (OTCQB: AYTU), a specialty ... related conditions, announced today that it has closed the ... financing, raising a total of $5.175 million, which includes ... Josh Disbrow , Chief Executive Officer ... intended to be used to conduct clinical studies for ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 ... BVXV) today announced the intent of the National Institute of ... Institutes of Health (NIH) within the Department of Health and ... to be held in the United States ... use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as ...
(Date:9/2/2015)... ... 02, 2015 , ... Whitehouse Laboratories is excited to announce ... Resources upcoming educational seminar and training session on Extractable & Leachable testing. Featuring ... provide Updates & Case Studies on the Latest Compliance Implications of USP and ...
(Date:9/2/2015)... Telford, England (PRWEB) , ... September 02, 2015 ... ... for drug discovery and life science research, today unveiled Genedata Screener ® ... platform for all in-vitro screening brings to market a rich set of new ...
Breaking Biology Technology:Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4
... Electroporator 2510 , , , , , , , , ... Protocol No. 4308 915.512 04/2002 , , , , ... , Microorganism , Escherichia coli DH5alpha, ... , Bacteria, gram negative, , ...
... , Multiporator , , , , , , , ... Protocol No. 4308 915.022 11/1999 , , , ... , Cell line , COS-7, monkey, ... , Plasmid RSV/lacZ (in bidistilled H 2 O), , ...
... , , , , Multiporator / Electroporator 2510 , , , ... Transformation Protocol , Protocol No. 4308 915.509 12/2001 , ... , , , , ... , Cell type , Bacteria, gram positive, ...
Cached Biology Technology:Escherichia coli DH5 2Escherichia coli DH5 3COS-7 2Clostridium botulinum 2
(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
(Date:8/12/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is proud to announce that iMedNet ... technology platform, has led the way to significant and ... 2015.   Q2 2015 and Q1 2015 were, respectively, ... value sold in the company,s 15 year history.  In ...
(Date:8/11/2015)... , August 11, 2015 Today, ZUK announced ... received as well as expected revenues in 2015 that relate to ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ... a prominent smartphone manufacturer in ... selected FPC1 155 for ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... we'd all agree it's not worthless. So, what's the ... 1997, the University of Vermont's Robert Costanza and his ... in a now-famous paper in the journal Nature. In ... bloomed. This young discipline studies how nature--through climate regulation, ...
... A new study by University of Georgia researchers shows ... control disease outbreaks can actually make matters worse in ... 7 edition of the journal Proceedings of the Royal ... Pejman Rohani, associate professor of ecology and UGA Biomedical ...
... in which monkeys were asked to manipulate computer cursors ... "executive" center plans behaviors not by specifying movements required ... result from those actions. , The distinction is significant, ... into a central function of behavioral planning in this ...
Cached Biology News:What's nature worth? New computer models tell all 2UGA researchers find that hunting can increase the severity of wildlife disease epidemics 2The brain's executive is an 'event planner' 2
The imaging screen-K (Kodak), tritium, is a 20 x 25 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
The filter 605DF50 for the Molecular Imager FX is a band pass filter for ethidium bromide, SYPRO Red, SYPRO Ruby, Alexa Fluor 532 and 546, and Cy3 dyes when using the 635 nm laser....
... The Model 175 tube gel cell is ... gels for 2-D electrophoresis applications. The upper ... OD tubes 9-23 cm long for isoelectric ... upper buffer chamber and cooling core, lower ...
Biology Products: